Genetic alterations that are already known occurred in thyroid cancer such as, RET/PTC (20%), all-RAS mutation (10%), and TRK (<5%) that might be present in our specimens but were not evaluated by this study (Kebebew et al., 2007). Here, RET is linked to thyroid cancer.